Prudential Financial’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$52.3K Buy
+18,470
New +$62.6K ﹤0.01% 2307
2025
Q4
Sell
-14,865
Closed -$42.7K 2353
2025
Q3
$42.7K Hold
14,865
﹤0.01% 2354
2025
Q2
$35.8K Buy
+14,865
New +$31.2K ﹤0.01% 2364
2025
Q1
Sell
-591,505
Closed -$3.22M 2347
2024
Q4
$3.22M Sell
591,505
-52,600
-8% -$338K ﹤0.01% 1067
2024
Q3
$5.35M Buy
644,105
+46,223
+8% +$400K 0.01% 967
2024
Q2
$4.28M Buy
+597,882
New +$5.16M 0.01% 999
2024
Q1
Sell
-269,608
Closed -$1.77M 2723
2023
Q4
$1.77M Buy
269,608
+54,713
+25% +$353K ﹤0.01% 1517
2023
Q3
$2.06M Buy
214,895
+289
+0.1% +$3.17K ﹤0.01% 1342
2023
Q2
$2.67M Sell
214,606
-11,287
-5% -$152K ﹤0.01% 1231
2023
Q1
$3.16M Buy
225,893
+46,135
+26% +$663K 0.01% 1063
2022
Q4
$2.57M Buy
179,758
+168,699
+1,525% +$2.66M ﹤0.01% 1177
2022
Q3
$282K Sell
11,059
-1,226,043
-99% -$30.8M ﹤0.01% 2333
2022
Q2
$35.1M Buy
1,237,102
+737,313
+148% +$23.4M 0.06% 318
2022
Q1
$17.6M Buy
499,789
+484,257
+3,118% +$16.2M 0.02% 534
2021
Q4
$652K Buy
+15,532
New +$629K ﹤0.01% 2097

Other funds holding MRVI

Prudential Financial's MRVI Position: Q1 2026 in Review

Prudential Financial opened a new position in Maravai LifeSciences (MRVI) in Q1 2026: 18,470 shares worth $52.3K. The stake represents ﹤0.01% of the portfolio and ranks #2307 among its holdings. This is a return to the name: Prudential Financial previously reported a position in MRVI as recently as Q3 2025.

Prudential Financial first reported a position in MRVI in Q4 2021 and has held it in 15 quarters since. The position peaked at $35.1M in Q2 2022. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Prudential Financial held 18,470 shares of Maravai LifeSciences worth $52.3K as of Q1 2026.
  • Maravai LifeSciences was a new Prudential Financial position in Q1 2026.
  • Maravai LifeSciences made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2307 holding.
  • Prudential Financial first reported a position in Maravai LifeSciences in Q4 2021 and has held it in 15 quarters since.
  • Prudential Financial's Maravai LifeSciences position peaked at $35.1M in Q2 2022.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.